Completed
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
NCT00943592
- Conditions
- Advanced Hematologic Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States